[HTML][HTML] Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - … & Molecular Medicine, 2021 - nature.com
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs.

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - … & Molecular Medicine, 2021 - europepmc.org
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

[HTML][HTML] Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - … & Molecular Medicine, 2021 - ncbi.nlm.nih.gov
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - EXPERIMENTAL …, 2021 - scholarworks.bwise.kr
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs.

J Seo, J Do Yoo, M Kim, G Shim… - Experimental & …, 2021 - search.ebscohost.com
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim… - Experimental & …, 2021 - pubmed.ncbi.nlm.nih.gov
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

JY Seo, JD Yoo, MS Kim, GY Shim… - Experimental & …, 2021 - oldkmbase.medric.or.kr
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - Experimental and …, 2021 - research.knu.ac.kr
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

J Seo, J Do Yoo, M Kim, G Shim, YK Oh… - Experimental and …, 2021 - pure.korea.ac.kr
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …

Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

S Junyoung, K Minseong, S Gayong… - Experimental & …, 2021 - search.proquest.com
Fibrin, one of the components of the extracellular matrix (ECM), acts as a transport barrier
within the core of tumors by constricting the blood vessels and forming clots, leading to poor …